Keurig Dr Pepper heads into the back half of 2026 with an unusual split: short sellers are quietly adding to positions while the analyst community has spent the past two weeks raising targets and cheering the stock on.
The short side has grown more active this week. Short interest climbed 4% over the past five days to reach 4.5% of the free float — roughly 60.8 million shares. That marks a reversal from a broader pullback: shorts had trimmed positions sharply through most of July, with SI dropping from above 7% of float in late June to a trough near 4.3% in mid-to-late July before turning higher again. The rebuild is modest in absolute terms, but the timing — right after Q2 results — is worth flagging. Borrow conditions remain very easy. Availability is at 1,338%, meaning there are more than thirteen shares available to borrow for every one already out on loan, and cost to borrow is running at just 0.44%. There is no squeeze pressure here, and new short positions face minimal friction to enter.
Options traders are telling the opposite story. The put/call ratio has fallen to 0.35, more than 1.3 standard deviations below its 20-day average of 0.40 — meaning call demand is running unusually hot relative to recent norms. The PCR sits near the lower end of its 52-week range of 0.21 to 0.81. That shift has been consistent across the past two weeks, with the ratio stepping down from the 0.48 range in early July to its current level. Options positioning looks more constructive than at almost any point this year, a contrast to the short-side rebuild happening simultaneously.
The Street is tilting clearly bullish. JP Morgan lifted its target to $38 from $33 last month while holding Overweight, and UBS similarly moved to $38 from $34 with a Buy rating. This week, Evercore ISI raised its target to $32 from $30, though it kept the more cautious In-Line rating — a sign the less-convinced camp is at least acknowledging improving fundamentals. The consensus mean target is $35.65, implying roughly 19% upside from the current $30.01 close. The stock is down 3.6% on the week and nearly 5% over the past month, which explains part of the target-to-price gap but also leaves the Street looking increasingly disconnected from where the stock trades. The bull case centres on US coffee retail sales growing 2.1% and ready-to-drink beverages up 3.1%; bears focus on pro-forma leverage running at approximately 5.2x and the ongoing decline in brewer shipments — down around 25% in recent quarters — which represents about 20% of the coffee segment. Valuation is undemanding at 12.5x trailing earnings and an EV/EBITDA multiple of 8.9x, both drifting lower over the past month as the price has slipped. Among close peers, MNST fell 6.2% on the week, while KO held up far better, off just 0.6%.
The Q2 earnings reaction adds context. The stock fell 2.4% on the day of the August 6 print. A prior quarter produced a 1.7% one-day drop followed by a 4.5% five-day recovery — a pattern worth keeping in mind as the dust settles on the latest release. The next scheduled event is November 5.
The short score is stable at 41.8, sitting in the lower third of the universe — not a stock that screams short conviction in aggregate. What to watch is whether the short-interest rebuild accelerates from here, and whether the options market's call-heavy skew can hold even as the stock continues to drift below the analyst community's price targets.
See the live data behind this article on ORTEX.
Open KDP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
